Literature DB >> 27407973

Controlled FiO2 Therapy to Neonates by Oxygenhood in the Absence of Oxygen Analyzer.

S K Jatana1, S Dhingra2, Mng Nair3, G Gupta4.   

Abstract

BACKGROUND: A study was conducted to evaluate a system of standardizing the oxygen concentration inside the oxygen hood and to develop guidelines for controlled FiO2 administration by changing size of the hood, lid position on the hood and the oxygen flow rate, without an oxygen analyzer. The effect of low flow rates on carbon dioxide (CO2) retention was also studied.
METHOD: A dummy patient and thirty neonates, requiring oxygen to be delivered through head box, constituted the material for the study group. Oxygen content in the head box was measured using a standard oxygen analyzer while the size of head box, flow rate and lid position were changed independently and in combination. The head boxes were tested on a dummy patient. These results were analyzed, and applied to thirty neonates requiring oxygen therapy using a head box. RESULT: Volume of headbox had an inverse relation with the oxygen concentration inside the headbox and smaller sized headbox achieved more predictable oxygen concentration at all flow rates. Maximum difference in oxygen concentration by varying the lid position was seen in the large headbox. Keeping the variables constant, oxygen concentration was significantly lower in babies as compared to dummy. No significant CO2 retention was found at a flow rate of four litres per minute (lpm) in small and three lpm in a medium and large head box respectively, while lower flow rates were associated with CO2 retention.
CONCLUSION: It is possible to predict the oxygen concentration inside the head box without the use of oxygen analyzer. Larger head box and higher lid position, results in lower oxygen concentration, at a given oxygen flow rate. Oxygen concentration achieved in babies is lesser than the concentration achieved in a dummy. Flow rates of less than four lpm in small and three lpm in medium and large sized head boxes are associated with CO2 retention. These results are not applicable to infants weighing less than 2 kg.

Entities:  

Keywords:  Neonates; Oxygen concentration, Oxygen analyzer; Oxygen hood; Oxygen therapy

Year:  2011        PMID: 27407973      PMCID: PMC4925353          DOI: 10.1016/S0377-1237(07)80061-X

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  9 in total

1.  A new oxygen head box.

Authors:  Mukta M Jain; Arvind Shenoi; H Paramesh
Journal:  Indian Pediatr       Date:  2002-09       Impact factor: 1.411

2.  The oxygen radical disease in neonatology.

Authors:  O D Saugstad
Journal:  Indian J Pediatr       Date:  1989 Sep-Oct       Impact factor: 1.967

Review 3.  ABC of oxygen. Acute oxygen therapy.

Authors:  N T Bateman; R M Leach
Journal:  BMJ       Date:  1998-09-19

4.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

5.  Study of factors determining the oxygen concentration in the head box.

Authors:  S Jain; A Johri
Journal:  Indian Pediatr       Date:  1984-02       Impact factor: 1.411

6.  ACCP-NHLBI National Conference on Oxygen Therapy.

Authors: 
Journal:  Chest       Date:  1984-08       Impact factor: 9.410

7.  Oxygen therapy in pediatrics.

Authors:  S Deopujari
Journal:  Indian J Pediatr       Date:  2000-12       Impact factor: 1.967

Review 8.  Oxygen administration in infants.

Authors:  B Frey; F Shann
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

9.  Sound levels inside incubators and oxygen hoods used with nebulizers and humidifiers.

Authors:  R W Beckham; S C Mishoe
Journal:  Respir Care       Date:  1982-01       Impact factor: 2.258

  9 in total
  1 in total

Review 1.  Current concepts of oxygen therapy in neonates.

Authors:  Siddarth Ramji; Ola D Saugstad; Ashish Jain
Journal:  Indian J Pediatr       Date:  2014-10-18       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.